161 related articles for article (PubMed ID: 30001233)
21. Novel ALK fusion partners in lung cancer.
Iyevleva AG; Raskin GA; Tiurin VI; Sokolenko AP; Mitiushkina NV; Aleksakhina SN; Garifullina AR; Strelkova TN; Merkulov VO; Ivantsov AO; Kuligina ESh; Pozharisski KM; Togo AV; Imyanitov EN
Cancer Lett; 2015 Jun; 362(1):116-21. PubMed ID: 25813404
[TBL] [Abstract][Full Text] [Related]
22. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
[TBL] [Abstract][Full Text] [Related]
23. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
[TBL] [Abstract][Full Text] [Related]
24. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.
Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA
Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629
[TBL] [Abstract][Full Text] [Related]
25. Morphologic spectrum, immunohistochemical analysis, and clinical features of a series of granular cell tumors of soft tissues: a study from a tertiary referral cancer center.
Rekhi B; Jambhekar NA
Ann Diagn Pathol; 2010 Jun; 14(3):162-7. PubMed ID: 20471560
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
27. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
28. Dermatofibroma-like dermal non-neural granular cell tumor.
Kim NY; Jang JW; Huh YJ; Ro YS; Paik SS; Ko JY
J Cutan Pathol; 2023 Apr; 50(4):316-320. PubMed ID: 36178226
[TBL] [Abstract][Full Text] [Related]
29. Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation.
Georgantzoglou N; Green D; Winnick KN; Sumegi J; Charville GW; Bridge JA; Linos K
Genes Chromosomes Cancer; 2022 Aug; 61(8):471-480. PubMed ID: 35289445
[TBL] [Abstract][Full Text] [Related]
30. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
Ke L; Xu M; Jiang X; Sun X
Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
[TBL] [Abstract][Full Text] [Related]
31. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
[TBL] [Abstract][Full Text] [Related]
32. Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases.
Lazar AJ; Fletcher CD
Am J Surg Pathol; 2005 Jul; 29(7):927-34. PubMed ID: 15958858
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous VCL::ALK fusion ovoid-spindle cell neoplasm.
Helm M; Chang A; Fanburg-Smith JC; Zaenglein AL; Helm K
J Cutan Pathol; 2023 May; 50(5):405-409. PubMed ID: 36843055
[TBL] [Abstract][Full Text] [Related]
35. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
[TBL] [Abstract][Full Text] [Related]
36. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase expression in inflammatory pseudotumors.
Chan JK; Cheuk W; Shimizu M
Am J Surg Pathol; 2001 Jun; 25(6):761-8. PubMed ID: 11395553
[TBL] [Abstract][Full Text] [Related]
38. A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results.
Fujimoto M; Togashi Y; Matsuzaki I; Baba S; Takeuchi K; Inaba Y; Jinnin M; Murata SI
Hum Pathol; 2018 Oct; 80():99-103. PubMed ID: 29514107
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
[TBL] [Abstract][Full Text] [Related]
40. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
